In a recent
research presentation by Dr. Jessica Hoffman, she discussed how AMPA receptors
bound to TARP y-8 regulate voluntary alcohol intake in mice. Specifically, the study
focused on the differences between the responses of the male and female mice. The
experiments resulted in a lack of response from the female mice, while male mice
lessened their alcohol intake when exposed to the JNJ drug.
The researchers tested a selective inhibitor
of TARP y-8 called JNJ-55511118, an invasive modulator that inhibited the AMPA
receptors bound to TARP y-8. The mice were then exposed to operant self-administration
of sweetened alcohol. This allowed the researchers
to measure motivation and reinforcement. They used various methods for giving
the mice access to said alcohol, such as lever presses and head pokes. The
results showed that JNJ significantly reduced alcohol self-administration in
male mice yet did not reduce alcohol intake in female. To ensure the drug was not
reducing all motivated behavior, they tested mice on sucrose-only self-administration
and found that JNJ did not reduce sucrose responding in either sex. The
researchers also ruled out motor impairment through an open-field locomotor
test.
The researchers
found that their results suggested that the CaMKII-TARP y-8–AMPAR pathway
supports chronic alcohol self-administration. During the talk, Dr. Hoffman
suggested a possible outlet for these results in Alzheimer’s research. After digging
deeper into this, I found a study by another researcher who had explored the topic.
Dr. Sanna and his team found that “Alcohol use disorder (AUD) quickens the pace
of Alzheimer’s disease progression when paired with genetic susceptibility,”
according to their paper, “A History of Repeated Alcohol Intoxication Promotes
Cognitive Impairment and Gene Expression Signatures of Disease Progression in
the 3xTg Mouse Model of Alzheimer’s Disease.” In this study, the researchers took
Alzheimer’s-model mice and repeatedly exposed them to alcohol vapor chambers over
many weeks, then tested their memory. They found that the Alzheimer’s mice who
were exposed to alcohol lost their memory much earlier than they normally would.
This result surprised me, as I initially thought that introducing a depressant
to a disease like Alzheimer’s would slow memory degradation. While AMPARs were
not directly measured, the study shows that alcohol accelerates Alzheimer’s by
increasing excitatory signaling, which AMPARs contribute to.
Both this study and Dr. Hoffman’s
research show that alcohol dysregulates glutamatergic signaling, especially AMPA
receptor-related pathways. They both demonstrate that alcohol pushes neurons
towards hyperexcitability in both addiction and Alzheimer’s circuits. Dr. Sanna’s
team found that alcohol accelerates Alzheimer’s by dysregulating gene networks that
increase excitatory signaling and inflammation, while Dr. Hoffman’s study
showed that alcohol-reinforced behavior depends on TARP y-8-bound AMPARs. Together,
these results suggest alcohol heavily affect the glutamatergic AMPA receptor-mediated
mechanisms. Continuing research into this subject would be very interesting,
possibly even providing new treatments for Alzheimer’s disease or other related
conditions.
References:
Hoffman, J. L., Faccidomo, S.,
Saunders, B. L., Taylor, S. M., Kim, M., & Hodge, C. W. (2021). Inhibition
of AMPA receptors (AMPARs) containing transmembrane AMPAR regulatory protein γ‑8
with JNJ‑55511118 shows preclinical efficacy in reducing chronic repetitive
alcohol self‑administration. Alcoholism: Clinical and Experimental
Research, 45(7), 1424–1435. https://doi.org/10.1111/acer.14639
Scripps Research Communications
Office. (2023, June 12). Alcohol in excess hastens Alzheimer’s progression.
Neuroscience News. https://neurosciencenews.com/alcohol-genetics-alzheimers-23448
No comments:
Post a Comment